Definium Therapeutics, Inc. DFTX Stock Forecast
AI-powered price prediction and analysis for Definium Therapeutics, Inc. · Alpha · vs marketSwitch to Total
See DFTX's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Definium Therapeutics, Inc.
Definium Therapeutics, Inc. (DFTX) operates within the Life Sciences sector, specifically in the Medicinal Chemicals & Botanical Products industry.
Latest News
Where DFTX sits on the market map
Medicinal Chemicals & Botanical Products Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| DFTX Definium Therapeutics, Inc. | ▶ | $4.62B | – |
| TRLV Trulieve Cannabis Corp. | ▶ | $2.00B | – |
| CRON Cronos Group Inc. | ▲ | $1.18B | 16.9x |
| TLRY Tilray Brands, Inc. | ▼ | $458M | – |
| CGC Canopy Growth Corp | ▲ | $323M | – |
| GLAS Glass House Brands Inc. | ▲ | $315M | – |
| USNA Usana Health Sciences Inc | ▼ | $276M | – |
| ACB Aurora Cannabis Inc | ▶ | $245M | – |
| NAGE Niagen Bioscience, Inc. | ▶ | $208M | 13.0x |
| MDWD Mediwound Ltd. | ▼ | $161M | – |
| AAWH Ascend Wellness Holdings, Inc. | ▲ | $87M | – |
| BTMD Biote Corp. | ▲ | $41M | – |
| MRMD Marimed Inc. | ▲ | $25M | – |
| CFOO China Foods Holdings Ltd. | ▼ | $21M | – |
| MTEX Mannatech Inc | ▲ | $15M | – |
| ADIA Adia Med, Inc. | ▲ | $14M | – |
| NAII Natural Alternatives International Inc | ▲ | $8M | – |
| CYAN Cyanotech Corp | ▲ | $5M | – |
| AIBT Aibotics, Inc. | ▼ | $2M | – |
| NPHC Nutra Pharma Corp | ▼ | $720K | – |
| MEHA Functional Brands Inc. | ▼ | $310K | – |
| IMCC Im Cannabis Corp. | ▼ | $290K | – |
| BON Bon Natural Life Ltd | ▼ | N/A | – |
| CBDY Target Group Inc. | ▲ | N/A | – |
| CHUC Charlie's Holdings, Inc. | ▶ | N/A | – |
| FTLF Fitlife Brands, Inc. | ▲ | N/A | – |
| GLUC Glucose Health, Inc. | ▼ | N/A | – |
| HYEX Healthy Extracts Inc. | ▶ | N/A | – |
| NTRR Neutra Corp. | ▼ | N/A | – |
| PLSH Panacea Life Sciences Holdings, … | ▲ | N/A | – |
| SNDL Sndl Inc. | ▼ | N/A | – |
FAQ
Is Definium Therapeutics, Inc. a good stock to buy?
Our AI analyzes Definium Therapeutics, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Definium Therapeutics, Inc. predictions?
A per-ticker accuracy statistic for DFTX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Definium Therapeutics, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Definium Therapeutics, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.